Ignite Creation Date:
2025-12-24 @ 7:17 PM
Ignite Modification Date:
2025-12-29 @ 6:56 PM
Study NCT ID:
NCT04493203
Status:
COMPLETED
Last Update Posted:
2025-07-15
First Post:
2020-07-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma
Sponsor:
Yana Najjar
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HCC 20-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None